Roundhill GLP-1 & Weight Loss ETF
OZEM
#3142
ETF rank
C$77.79 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$42.51
Share price
-2.14%
Change (1 day)
-6.36%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of November 17, 2026Number of holdings: 24

Full holdings list

Weight %NameTickerISINShares Held
20.49%
Eli Lilly & CoLLYUS53245710838083
10.92%
Novo Nordisk A/SNVOUS6701002056149897
7.20%
Chugai Pharmaceutical Co Ltd4519 JPJP351940000087300
6.90%
Hanmi Pharm Co Ltd128940 KSKR712894000411503
5.77%
Pfizer IncPFEUS7170811035113197
4.62%
Kailera Therapeutics IncKLRAUS4829311020211629
4.61%
CSPC Pharmaceutical Group Ltd1093 HKHK10930121722560000
4.14%
Jiangsu Hengrui Pharmaceuticals Co Ltd1276 HKCNE100006XS6380200
3.77%
Hansoh Pharmaceutical Group Co Ltd3692 HKKYG549581067494000
3.73%
Viking Therapeutics IncVKTXUS92686J106077574
3.27%
AstraZeneca PLCAZNGB000989529210026
3.21%
Ascletis Pharma Inc1672 HKKYG0520K10943227000
3.04%
Zealand Pharma A/SZEAL DCDK006025781450254
3.02%
Amgen IncAMGNUS03116210093689
2.79%
Roche Holding AGROP SWCH14990599833213
2.77%
Structure Therapeutics IncGPCRUS86366E106485120
2.10%
Gubra A/SGUBRA DCDK006226647427580
2.05%
United Laboratories International Holdings Ltd/The3933 HKKYG8813K10851222000
1.86%
Innovent Biologics Inc1801 HKKYG4818G101095000
1.71%
MBX Biosciences IncMBXUS55287L101718003
1.45%
Gilead Sciences IncGILDUS37555810364756
0.71%
First American Government Obligations Fund 12/01/2031FGXXX398085.19
0.31%
Cash & OtherCash&Other173610.55
-0.46%
SWISS FRANCCHF-215321.29